Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioqual Inc. stock logo
BIOQ
Bioqual
$43.55
+0.3%
$43.30
$43.19
$72.50
$38.95M-0.1117 shs332 shs
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
$9.00
+2.2%
$7.76
$3.36
$13.69
$202.74MN/A569,116 shs8.85 million shs
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$1.42
$1.78
$1.26
$5.20
$151.38M1.2977,854 shs628,848 shs
Veritone, Inc. stock logo
VERI
Veritone
$3.64
-5.2%
$2.41
$1.22
$5.64
$212.24M3.053.21 million shs10.09 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioqual Inc. stock logo
BIOQ
Bioqual
0.00%+0.84%+0.84%-1.58%-37.78%
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
+21.69%+35.12%-11.37%+38.52%+880,999,900.00%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
+0.71%+5.97%+2.90%-38.26%-62.92%
Veritone, Inc. stock logo
VERI
Veritone
+46.01%+23.47%+35.21%+149.35%+32.87%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bioqual Inc. stock logo
BIOQ
Bioqual
$43.55
+0.3%
$43.30
$43.19
$72.50
$38.95M-0.1117 shs332 shs
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
$9.00
+2.2%
$7.76
$3.36
$13.69
$202.74MN/A569,116 shs8.85 million shs
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$1.42
$1.78
$1.26
$5.20
$151.38M1.2977,854 shs628,848 shs
Veritone, Inc. stock logo
VERI
Veritone
$3.64
-5.2%
$2.41
$1.22
$5.64
$212.24M3.053.21 million shs10.09 million shs
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bioqual Inc. stock logo
BIOQ
Bioqual
0.00%+0.84%+0.84%-1.58%-37.78%
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
+21.69%+35.12%-11.37%+38.52%+880,999,900.00%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
+0.71%+5.97%+2.90%-38.26%-62.92%
Veritone, Inc. stock logo
VERI
Veritone
+46.01%+23.47%+35.21%+149.35%+32.87%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bioqual Inc. stock logo
BIOQ
Bioqual
0.00
N/AN/AN/A
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
0.00
N/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
2.50
Moderate Buy$7.00392.96% Upside
Veritone, Inc. stock logo
VERI
Veritone
3.00
Buy$5.0037.36% Upside

Current Analyst Ratings Breakdown

Latest BIOQ, MIMI, MXCT, and VERI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/2/2025
Veritone, Inc. stock logo
VERI
Veritone
D Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong-Buy
9/2/2025
Veritone, Inc. stock logo
VERI
Veritone
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$6.00
8/11/2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuyNeutral
8/8/2025
Veritone, Inc. stock logo
VERI
Veritone
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$4.00
8/7/2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
William Blair
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperformMarket Perform
7/22/2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$6.00
7/15/2025
Veritone, Inc. stock logo
VERI
Veritone
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$4.00
7/3/2025
Veritone, Inc. stock logo
VERI
Veritone
D. Boral Capital
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$4.00
(Data available from 9/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bioqual Inc. stock logo
BIOQ
Bioqual
$58.59M0.66N/AN/AN/A
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
N/AN/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$38.63M3.92N/AN/A$1.95 per share0.73
Veritone, Inc. stock logo
VERI
Veritone
$92.64M2.17N/AN/A$0.33 per share11.03
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bioqual Inc. stock logo
BIOQ
Bioqual
$480K-$2.39N/AN/A-4.34%-5.82%-3.79%10/20/2025 (Estimated)
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
N/AN/A0.00N/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$41.06M-$0.43N/AN/AN/A-125.22%-22.12%-19.10%11/5/2025 (Estimated)
Veritone, Inc. stock logo
VERI
Veritone
-$37.38M-$0.83N/AN/A-40.29%-4,022.14%-18.62%11/11/2025 (Estimated)

Latest BIOQ, MIMI, MXCT, and VERI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2025Q2 2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.10-$0.12-$0.02-$0.12$9.57 million$8.51 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bioqual Inc. stock logo
BIOQ
Bioqual
$0.501.15%N/AN/A N/A
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
N/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/AN/AN/AN/AN/A
Veritone, Inc. stock logo
VERI
Veritone
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bioqual Inc. stock logo
BIOQ
Bioqual
N/A
5.08
5.08
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
N/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/A
12.40
11.71
Veritone, Inc. stock logo
VERI
Veritone
89.57
0.89
0.89

Institutional Ownership

CompanyInstitutional Ownership
Bioqual Inc. stock logo
BIOQ
Bioqual
N/A
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
N/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
68.81%
Veritone, Inc. stock logo
VERI
Veritone
39.18%

Insider Ownership

CompanyInsider Ownership
Bioqual Inc. stock logo
BIOQ
Bioqual
39.24%
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
N/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.30%
Veritone, Inc. stock logo
VERI
Veritone
14.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bioqual Inc. stock logo
BIOQ
Bioqual
114890,000543,000Not Optionable
Mint Incorporation Limited stock logo
MIMI
Mint Incorporation
1523.01 millionN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
80106.61 million103.09 millionOptionable
Veritone, Inc. stock logo
VERI
Veritone
55055.27 million47.53 millionOptionable

Recent News About These Companies

Veritone Announces Proposed Public Offering of Common Stock
Veritone management to meet with Needham
Veritone's (VERI) Buy Rating Reaffirmed at D. Boral Capital
Veritone Sees Way to Profitability Next Year
Ryan Steelberg
Newsmax Shares Rise After Partnership With Veritone
Midday Stock Roundup: Veritone Slides
Veritone, Inc. (NASDAQ:VERI) Short Interest Update
UBS Remains a Hold on Veritone (VERI)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bioqual stock logo

Bioqual OTCMKTS:BIOQ

$43.55 +0.11 (+0.26%)
As of 09/8/2025 10:49 AM Eastern

Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is based in Rockville, Maryland.

Mint Incorporation stock logo

Mint Incorporation NASDAQ:MIMI

$9.00 +0.19 (+2.16%)
As of 04:00 PM Eastern

Mint, Inc. Ltd. is a company that engages in the provision of interior design and fit works. The company offers design services including layout plans and sketches presented in the form of 3d technical drawing and design and fit out services. The company was founded in 2018 and is headquartered in Hong Kong.

MaxCyte stock logo

MaxCyte NASDAQ:MXCT

$1.42 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.41 -0.01 (-0.70%)
As of 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

Veritone stock logo

Veritone NASDAQ:VERI

$3.64 -0.20 (-5.21%)
Closing price 04:00 PM Eastern
Extended Trading
$3.13 -0.51 (-14.12%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Veritone, Inc., together with its subsidiaries, engages in the provision of artificial intelligence (AI) computing solutions and services in the United States, the United Kingdom, France, Australia, Israel, and India. It develops and operates aiWARE platform, an AI operating system, that uses machine learning algorithms or AI models designed to mimic human cognitive functions, such as perception, prediction, and problem solving and optimization, as well as enables users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. The company also provides media advertising agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics directly to advertisers through outbound sales networking, and client and partner referrals, as well as indirectly through advertising agencies or marketing consultants. It serves media and entertainment, government, legal and compliance, energy, and other vertical markets. The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.